BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 12680478)

  • 1. Thalidomide for erythema nodosum leprosum and other applications.
    Okafor MC
    Pharmacotherapy; 2003 Apr; 23(4):481-93. PubMed ID: 12680478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The promise of thalidomide: evolving indications.
    Joglekar S; Levin M
    Drugs Today (Barc); 2004 Mar; 40(3):197-204. PubMed ID: 15148528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thalidomide: current and potential clinical applications.
    Calabrese L; Fleischer AB
    Am J Med; 2000 Apr; 108(6):487-95. PubMed ID: 10781782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential novel uses of thalidomide: focus on palliative care.
    Peuckmann V; Fisch M; Bruera E
    Drugs; 2000 Aug; 60(2):273-92. PubMed ID: 10983733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide in the treatment of erythema nodosum leprosum (ENL) in an outpatient setting: A five-year retrospective analysis from a leprosy referral centre in India.
    Upputuri B; Pallapati MS; Tarwater P; Srikantam A
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008678. PubMed ID: 33035210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thalidomide's effectiveness in erythema nodosum leprosum is associated with a decrease in CD4+ cells in the peripheral blood.
    Shannon EJ; Ejigu M; Haile-Mariam HS; Berhan TY; Tasesse G
    Lepr Rev; 1992 Mar; 63(1):5-11. PubMed ID: 1569817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide: a review of approved and investigational uses.
    Matthews SJ; McCoy C
    Clin Ther; 2003 Feb; 25(2):342-95. PubMed ID: 12749503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose-dependent thalidomide induced bradycardia in young erythema nodosum leprosum patient.
    Thangaraju P; Venkatesan S; Sivashanmugam E; Showkath Ali MK
    Indian J Pharmacol; 2019; 51(1):72-74. PubMed ID: 31031470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Japanese guideline on thalidomide usage in the management of erythema nodosum leprosum].
    Ishii N; Ishida Y; Okano Y; Ozaki M; Gidoh M; Kumano K; Goto M; Nogami R; Hatano K; Yamada A; Yotsu RR
    Nihon Hansenbyo Gakkai Zasshi; 2011 Sep; 80(3):275-85. PubMed ID: 21941834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.
    Schmitz V; Prata RB; Barbosa MG; Mendes MA; Brandão SS; Amadeu TP; Rodrigues LS; Ferreira H; Costa Fda M; Dos Santos JB; Pacheco Fdos S; Machado Ade M; Nery JA; Hacker Mde A; Sales AM; Pinheiro RO; Sarno EN
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004955. PubMed ID: 27556927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pentoxifylline in the treatment of erythema nodosum leprosum: results of an open study].
    de Carsalade GY; Achirafi A; Flageul B
    Acta Leprol; 2003; 12(3):117-22. PubMed ID: 15040702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thalidomide: a re-look.
    Grover JK; Vats V; Gopalakrishna R; Ramam M
    Natl Med J India; 2000; 13(3):132-41. PubMed ID: 11558112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thalidomide in erythema nodosum leprosum (ENL).
    Bourdillon C
    Lepr Rev; 1988 Jun; 59(2):184-5. PubMed ID: 3246930
    [No Abstract]   [Full Text] [Related]  

  • 14. [Thalidomide: new uses for an old drug].
    Wu KL; Sonneveld P
    Ned Tijdschr Geneeskd; 2002 Aug; 146(31):1438-41. PubMed ID: 12190008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thalidomide in the treatment of leprosy.
    Teo S; Resztak KE; Scheffler MA; Kook KA; Zeldis JB; Stirling DI; Thomas SD
    Microbes Infect; 2002 Sep; 4(11):1193-202. PubMed ID: 12361920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case report of venous thrombosis in a leprosy patient treated with corticosteroid and thalidomide.
    Vetrichevvel TP; Pise GA; Thappa DM
    Lepr Rev; 2008 Jun; 79(2):193-5. PubMed ID: 18711941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions for erythema nodosum leprosum.
    Van Veen NH; Lockwood DN; van Brakel WH; Ramirez J; Richardus JH
    Cochrane Database Syst Rev; 2009 Jul; (3):CD006949. PubMed ID: 19588412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum.
    Sampaio EP; Kaplan G; Miranda A; Nery JA; Miguel CP; Viana SM; Sarno EN
    J Infect Dis; 1993 Aug; 168(2):408-14. PubMed ID: 8335978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of thalidomide in the management of erythema nodosum leprosum.
    Walker SL; Waters MF; Lockwood DN
    Lepr Rev; 2007 Sep; 78(3):197-215. PubMed ID: 18035771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of thalidomide's history and current dermatological applications.
    Perri AJ; Hsu S
    Dermatol Online J; 2003 Aug; 9(3):5. PubMed ID: 12952752
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.